CL
HZNP

CSS LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

CSS LLC’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-32,276
Closed -$3.73M – 1021
2023
Q3 		$3.73M Buy
32,276
+23,300
+260% +$2.5M 0.25% 77
2023
Q2 		$923K Buy
8,976
+5,500
+158% +$580K 0.06% 243
2023
Q1 		$379K Sell
3,476
-24
-0.7% -$2.65K 0.03% 399
2022
Q4 		$398K Buy
+3,500
New +$291K 0.02% 439
2021
Q1 		– Sell
-3,686
Closed -$269K – 1255
2020
Q4 		$269K Sell
3,686
-103,576
-97% -$7.7M 0.01% 585
2020
Q3 		$8.33M Buy
107,262
+1,500
+1% +$103K 0.39% 49
2020
Q2 		$5.88M Buy
+105,762
New +$4.52M 0.33% 76
2019
Q1 		– Sell
-406
Closed -$9.62K – 621
2018
Q4 		$8K Buy
+406
New +$7.96K ﹤0.01% 521
2018
Q1 		– Sell
-35,487
Closed -$524K – 658
2017
Q4 		$518K Hold
35,487
– – 0.03% 350
2017
Q3 		$450K Buy
35,487
+30,400
+598% +$387K 0.02% 373
2017
Q2 		$60K Sell
5,087
-36,200
-88% -$450K ﹤0.01% 590
2017
Q1 		$610K Sell
41,287
-29,173
-41% -$472K 0.04% 293
2016
Q4 		$1.14M Buy
70,460
+29,500
+72% +$535K 0.06% 225
2016
Q3 		$743K Buy
+40,960
New +$800K 0.04% 302
2016
Q1 		– Sell
-30,560
Closed -$535K – 771
2015
Q4 		$662K Buy
+30,560
New +$595K 0.04% 307

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

CSS LLC's HZNP Position: Q4 2023 in Review

CSS LLC sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 32,276 shares — an estimated $3.73M sold.

CSS LLC first reported a position in HZNP in Q4 2015 and held it in 15 quarters. The position peaked at $8.33M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • CSS LLC reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • CSS LLC sold 32,276 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $3.73M.
  • CSS LLC first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 15 quarters.
  • CSS LLC's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $8.33M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on CSS LLC's 13F filing for Q4 2023, filed 14 Feb 2024.